Paper Title
Randomised controlled trial comparing Myo-inositol with Metformin in patients with polycystic ovary syndrome
Article Identifiers
Registration ID: IJNRD_210608
Published ID: IJNRD2312392
: Click Here to Get
About Hard Copy and Transparent Peer Review Report
Authors
Keywords
PCOS, Myo-inositol, Metformin, Insulin Resistance
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age group affecting approximately, 4 – 15 % of female population. PCOD is no longer disorder confined to ovary, but involves a complex pathophysiology of multiple organs like hypothalamus, pituitary, adrenals and adipose tissue. Environmental factors like stress, life style changes including increased fat, carbohydrate diet and reduced physical activity are important contributing factors. Genetic factors include mutations in genes coding for CYP450 enzymes like CYP 11A1, CYP 21A1 and defects in enzymes involved in cholesterol metabolism and androgen synthesis. Diagnosis is based on consensus oligo / anovulation, hyperandrogenism, polycystic ovaries, with exclusion of other endocrine disorders. Anovulation in PCOS is due to inappropriate gonadotropin secretion. This leads to preferential production of luteinizing hormone (LH) compared to follicle stimulating hormone (FSH) and LH:FSH ratio becomes 2:1 or even 3:14. Insulin resistance is common in approximately 60 – 70% of women with PCOS. IR is reduced response of peripheral tissues to insulin. It is due to phosphorylation of serine residues of insulin receptor leading to post binding abnormality in receptor mediated signal transduction. IR is sensed by pancreas as insulin deficiency and leads to compensatory hyperinsulinemia. This excess insulin stimulates luteinizing hormone (LH) to produce more androgens from theca cells of ovary leading to features of hyperandrogenism. Increased androgens, prevent maturation of one dominant follicle as Graafian follicle and also prevent apoptosis of small follicles, which are normally destined to disappear. This gives the appearance of polycystic ovaries in ultrasound as necklace like pattern in the peripheral rim of ovary. In addition, life style modifications like regular exercise and balanced diet are the first line management. Insulin sensitizers like metformin are used to avoid and treat metabolic disorders associated with IR such as diabetes, dyslipidemia and cardiovascular events. But this is associated with gastrointestinal adverse effects like nausea, diarrhea, dyspepsia, flatulence and abdomen pain. This leads to poor patient compliance. Inositol is a polyalcohol, a physiological compound of sugar family of which two stereoisomers are found in our body, Myo-inositol (MI) and D-chiro inositol (DCI). MI is very scarce in diet and synthesized endogenously from Myo inositol by insulin dependent epimerase enzyme. D-chiro-inositol is an important second messenger in insulin signal transduction. It acts as a precursor for inositol triphosphate (IP3) and phosphatidyl inositol 3 kinase (PI3K), needed for actions of insulin like increased glucose uptake, thus improving insulin sensitivity. Thus, MI can be used as an alternative to metformin to improve insulin sensitivity. Certain studies have demonstrated the efficacy of MI in reducing metabolic and endocrinological abnormalities in PCOS patient. This study was undertaken to demonstrate the efficacy and safety of Myo-inositol, since limited studies are available in India regarding supplementation of Myo-inositol in PCOS.
Downloads
How To Cite (APA)
S. Ramya, S. Swarnalatha, R. Rajesh, S. Priyanka, & S. Deepika (December-2023). Randomised controlled trial comparing Myo-inositol with Metformin in patients with polycystic ovary syndrome . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(12), d836-d845. https://ijnrd.org/papers/IJNRD2312392.pdf
Issue
Volume 8 Issue 12, December-2023
Pages : d836-d845
Other Publication Details
Paper Reg. ID: IJNRD_210608
Published Paper Id: IJNRD2312392
Research Area: Pharmacy
Author Type: Indian Author
Country: Chennai, Tamil Nadu, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2312392.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2312392
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International UGC CARE JOURNAL PUBLICATION, Low Cost, Scholarly Open Access, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Copyright & License
© 2026 - Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0).
🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use.
The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the New UGC CARE Transparent Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.
IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.
Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.
Transparent Peer Review Journal Publication: IJNRD operates a strict double-blind peer review system managed by 3000+ expert reviewers, ensuring ethical, unbiased, and high-quality review for every research paper.
For Indian Authors : Get a transparent peer review report from Scholar9.com for just ₹1000. View Sample Report
For Foreign Authors : A detailed peer review report is available through Scholar9.com for $20 USD. View Sample Report
Transparent Peer Review Journal Publication
⭐ Transparent Peer Review | 🕵️♂️ Double-Blind | 👨🏫 3000+ Expert Reviewers | 🇮🇳 Report for India Author ₹1000 | 🌐 Report for Foreign Author $20 | 📄 Sample Reports on Scholar9.com | 🌍 High Credibility | ⚖️ Ethical & Unbiased Evaluation
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Recently, the UGC discontinued the UGC-CARE Journal List and introduced new parameters that allow publication in Transparent Peer-Reviewed (Refereed) Journals. IJNRD is Transparent Peer Review Journal Valid As per New UGC Notification.
You can now publish your research paper in IJNRD.ORG. IJNRD is a Transparent Peer-Reviewed Open Access (Refereed Journal), UGC and UGC CARE Approved, Crossref DOI, Multidisciplinary, Impact Factor calculate by Google Scholar. As an International, open-access, and online journal, Publishing with us ensures wider reach, academic credibility, and enhanced recognition for your work.
For more details, refer to the official notice: UGC Public Notice
⭐ Low Cost ₹1570 | 📚 UGC CARE Approved | 🔍 Peer-Reviewed | 🌐 Open Access | 🔗 Crossref DOI & Global Indexing | 📊 Google Scholar Impact Factor | 🧪 Multidisciplinary
Submit Paper Online Call for Paper About IJNRD UGC CARE Approval
Important Dates for Current issue
Paper Submission Open For: May 2026
Current Issue: Volume 11 | Issue 5 | May 2026
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-May-2026
Notification of Review Result: Transparent peer review process - your paper is evaluated by experts, and you receive acceptance or rejection updates via email and SMS.
Publication of Paper: Once all documents are submitted, your paper is published without delay, and you can instantly download your certificate and confirmation letter online.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an international open-access journal offering Low Cost Journal Publication, transparent Peer Review Journal Publication, Crossref DOI, and multidisciplinary research visibility under UGC CARE Approved Journal Publication.
Subject Category: Research Area
Approval, Licenses and Indexing: More Details
Call For Paper - Volume 11 | Issue 5 | May 2026
IJNRD.org offers low-cost journal publication starting at ₹1570 with UGC CARE Approved, refereed, peer-reviewed, open-access publishing. This multidisciplinary monthly journal, available in both online and print formats, features a strong Google Scholar-based impact factor of 8.76, Transparent Peer Review, CrossRef DOI, global indexing, fast publication, and complete metadata for maximum research visibility and citation impact across multidisciplinary domains.
Volume 11 | Issue 5 | May 2026 | IJNRD Transparent Peer Review Certificate | Submit Paper Online
⭐ UGC CARE Approved Refereed Journal | 🔍 Transparent Peer Review | 🌐 Open Access Publishing | 💰 Low-Cost ₹1570 | 🔗 CrossRef DOI & Global Indexing | 📊 Google Scholar Impact Factor 8.76 | 🧪 Multidisciplinary | Online & Print
Submit Paper Online
